Overview and Scope
Inflammatory bowel disease treatment refers to anti-inflammatory medications that are commonly used to treat mild to moderate ulcerative colitis. Aminosalicylates such as mesalamine (Delzicol, Rowasa, and other brands), balsalazide (Colazal), and olsalazine are anti-inflammatories (Dipentum).
Sizing and Forecast
The inflammatory bowel disease treatment market size has grown strongly in recent years. It will grow from $23.49 billion in 2023 to $25.56 billion in 2024 at a compound annual growth rate (CAGR) of 8.8%. The growth in the historic period can be attributed to increased prevalence of inflammatory bowel disease, growing demand for biologics and immunomodulators, advancements in treatment options, rising geriatric population, increased awareness about the disease.
The inflammatory bowel disease treatment market size is expected to see strong growth in the next few years. It will grow to $36.63 billion in 2028 at a compound annual growth rate (CAGR) of 9.4%. The growth in the forecast period can be attributed to increasing investment in research and development activities, growing demand for biosimilars, rising incidence of inflammatory bowel disease in emerging markets, growing demand for personalized medicine, integration of precision medicine in ibd treatment. Major trends in the forecast period include increasing number of product launches and approvals, personalized dosing and treatment plans in ibd management, use of telemedicine for remote monitoring of ibd patients, exploration of microbiome-based therapies for ibd, adoption of value-based care models in ibd treatmen.
To access more details regarding this report, visit the link:
https://www.thebusinessresearchcompany.com/report/inflammatory-bowel-disease-treatment-global-market-report
Segmentation & Regional Insights
The inflammatory bowel disease treatment market covered in this report is segmented –
1) By Drug Class: Aminosalicylates, Corticosteroids, TNF inhibitors, IL inhibitors, Anti-integrin, JAK inhibitors, Other Drug Classes
2) By Type: Crohn’s Disease, Ulcerative Colitis
3) By Route of Administration: Oral, Injectable
4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy
North America was the largest region in the inflammatory bowel disease treatment market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the inflammatory bowel disease treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Intrigued to explore the contents? Secure your hands-on sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=6704&type=smp
Major Driver Impacting Market Growth
The rising prevalence of Crohn’s disease and ulcerative colitis is significantly driving the inflammatory bowel disease treatment market. Crohn’s disease and ulcerative colitis are types of inflammatory bowel diseases (IBD) that cause inflammation and ulcers (sores) in the digestive tracts. The rising cases of Crohn’s disease and ulcerative colitis are expected to boost demand for inflammatory bowel disease treatments, as they are widely used to reduce bowel inflammation and reduce and prevent medical complications. For instance, according to March 2022 research published in the United States National Library of Medicine, a US-based medical library, around 1.6 million Americans currently suffer from inflammatory bowel disease (Crohn’s disease or ulcerative colitis) and around 70,000 new cases of IBD are diagnosed every year in the USA. Hence, the rising prevalence of Crohn’s disease and ulcerative colitis is expected to drive the inflammatory bowel disease treatment market growth.
Key Industry Players
Major companies operating in the inflammatory bowel disease treatment market report are AbbVie Inc., Biogen Inc., Johnson & Johnson, Amgen Inc., Union Chimique Belge S. A., Advanced Gastroenterology and Surgery Associates P. A., Atlanta Gastroenterology Associates LLC, Boehringer Ingelheim International GmbH, Bristol-Myers Squibb Company, Cedars-Sinai Medical Center, Celgene Corporation, Cleveland Clinic Foundation, Digestive Disease Associates of Rockland P. C., Eli Lilly and Company, Gastrointestinal Specialists Inc., Gilead Sciences Inc., GlaxoSmithKline plc, Illinois Gastroenterology Group LLC, The Johns Hopkins Hospital Inc., Massachusetts General Hospital, Mayo Clinic, Merck & Co. Inc., Mount Sinai Health System Inc., Novartis International AG, Pfizer Inc., F. Hoffmann-La Roche Ltd, Takeda Pharmaceutical Company Limited, Texas Digestive Disease Consultants P. A., The Oregon Clinic – Gastroenterology West P. C., Ebony 60 Inc., Salix Pharmaceuticals Inc., Shire plc, Vifor Pharma AG, Zydus Pharmaceuticals (USA) Inc.
The inflammatory bowel disease treatment market report table of contents includes:
1. Executive Summary
2. Inflammatory Bowel Disease Treatment Market Characteristics
3. Inflammatory Bowel Disease Treatment Market Trends And Strategies
4. Inflammatory Bowel Disease Treatment Market – Macro Economic Scenario
5. Global Inflammatory Bowel Disease Treatment Market Size and Growth
.
.
.
31. Global Inflammatory Bowel Disease Treatment Market Competitive Benchmarking
32. Global Inflammatory Bowel Disease Treatment Market Competitive Dashboard
33. Key Mergers And Acquisitions In The Inflammatory Bowel Disease Treatment Market
34. Inflammatory Bowel Disease Treatment Market Future Outlook and Potential Analysis
35. Appendix
Top Major Players:
AbbVie Inc
Biogen Inc
Amgen Inc.
Union Chimique Belge S. A
Advanced Gastroenterology and Surgery Associates P. A.
Explore the trending research reports from TBRC:
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
